Gregory M. Glenn, President, R&D at NOVAVAX INC (NVAX), sold 7,102 shares at $230.52 ($1.7M) on 2021-08-26, disclosed to the SEC on 2021-08-30.
Open-market sale of $1.7M NVAX by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $227.74 | 100 | $23K | 1.4% |
| 2 | $229.35 | 200 | $46K | 2.8% |
| 3 | $230.34 | 72 | $17K | 1.0% |
| 4 | $230.34 | 1,296 | $299K | 18.0% |
| 5 | $230.52 | 605 | $139K | 8.4% |
| 6 | $230.52 | 605 |
| $139K |
| 8.4% |
| 7 | $231.35 | 400 | $93K | 5.6% |
| 8 | $232.89 | 700 | $163K | 9.8% |
| 9 | $233.89 | 616 | $144K | 8.7% |
| 10 | $233.89 | 616 | $144K | 8.7% |
| 11 | $235.27 | 400 | $94K | 5.7% |
| 12 | $236.13 | 200 | $47K | 2.9% |
| 13 | $237.35 | 400 | $95K | 5.7% |
| 14 | $238.62 | 346 | $83K | 5.0% |
| 15 | $238.62 | 346 | $83K | 5.0% |
| 16 | $240.04 | 100 | $24K | 1.4% |
| 17 | $241.57 | 100 | $24K | 1.5% |
| Total | $233.17 avg | 7,102 | $1.7M | 100% |
| Filing → |
| NVAX | SELL | 2021-12-09 | $1.6M | — | Filing → |
| NVAX | SELL | 2021-12-02 | $3.2M | — | Filing → |
| NVAX | SELL | 2021-11-30 | $719K | — | Filing → |